These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9118374)

  • 1. Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation.
    Stone NN; Stock RG
    Tech Urol; 1995; 1(2):72-80. PubMed ID: 9118374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate.
    Stone NN; Ramin SA; Wesson MF; Stock R; Unger P; Klein G
    J Urol; 1995 May; 153(5):1555-60. PubMed ID: 7536266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
    Stock RG; Stone NN
    Brachytherapy; 2002; 1(1):2-10. PubMed ID: 15062181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.
    Gelblum DY; Potters L; Ashley R; Waldbaum R; Wang XH; Leibel S
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):59-67. PubMed ID: 10477007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate brachytherapy: treatment strategies.
    Stone NN; Stock RG
    J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients.
    Sharkey J; Chovnick SD; Behar RJ; Perez R; Otheguy J; Solc Z; Huff W; Cantor A
    Urology; 1998 May; 51(5):796-803. PubMed ID: 9610594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 3-dimensional conformal radiotherapy and transperineal Pd-103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer.
    Singh A; Zelefsky MJ; Raben A; Lombardi D; Leibel SA
    Int J Cancer; 2000 Oct; 90(5):275-80. PubMed ID: 11091351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy.
    Sharkey J; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R; Steele J; Webster C; Donohue M; Solc Z; Huff W; Cantor A
    J Endourol; 2000 May; 14(4):343-50. PubMed ID: 10910150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma.
    Dattoli M; Wallner K; Sorace R; Koval J; Cash J; Acosta R; Brown C; Etheridge J; Binder M; Brunelle R; Kirwan N; Sanchez S; Stein D; Wasserman S
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):875-9. PubMed ID: 8751395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer.
    Stone NN; Stock RG; Unger P; Kao J
    J Endourol; 2000 May; 14(4):375-80. PubMed ID: 10910155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review on the effectiveness of prostate cancer brachytherapy].
    Inciūra A; Jarusevicus L; Vaiciūnas K; Juozaityte E
    Medicina (Kaunas); 2009; 45(8):660-71. PubMed ID: 19773626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
    Dinges S; Deger S; Koswig S; Boehmer D; Schnorr D; Wiegel T; Loening SA; Dietel M; Hinkelbein W; Budach V
    Radiother Oncol; 1998 Aug; 48(2):197-202. PubMed ID: 9783892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer with large glands treated with 3-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup.
    Koutrouvelis PG; Lailas N; Katz S; Sehn J; Gil-Montero G; Khawand N
    J Urol; 2003 Apr; 169(4):1331-6. PubMed ID: 12629354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer.
    Sharkey J; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R; Solc Z; Huff W; Cantor A; Steele J; Webster C; Donohue M
    Tech Urol; 2000 Jun; 6(2):128-34. PubMed ID: 10798814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
    Ko EC; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):600-7. PubMed ID: 21985944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate.
    Stokes SH; Real JD; Adams PW; Clements JC; Wuertzer S; Kan W
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):337-41. PubMed ID: 9069305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
    Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.